Cargando…

The THINC-it Tool for Cognitive Assessment and Measurement in Major Depressive Disorder: Sensitivity to Change

BACKGROUND: Herein, we sought to determine the sensitivity to change in cognitive function, as measured by the THINC-it tool, in a sample of adults with major depressive disorder (MDD) receiving standardized antidepressant therapy. METHODS: Adults meeting the DSM-5 criteria for MDD with at least mod...

Descripción completa

Detalles Bibliográficos
Autores principales:	McIntyre, Roger S., Subramaniapillai, Mehala, Park, Caroline, Zuckerman, Hannah, Cao, Bing, Lee, Yena, Iacobucci, Michelle, Nasri, Flora, Fus, Dominika, Bowie, Christopher R., Tran, Tanya, Rosenblat, Joshua D., Mansur, Rodrigo B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327547/ https://www.ncbi.nlm.nih.gov/pubmed/32670103 http://dx.doi.org/10.3389/fpsyt.2020.00546

Ejemplares similares

The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder
por: Cao, Bing, et al.
Publicado: (2019)

The Relationship Between Cognitive Dysfunction Through THINC-Integrated Tool (THINC-it) and Psychosocial Function in Chinese Patients With Major Depressive Disorder
por: Han, Han, et al.
Publicado: (2021)

Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder
por: Rong, Carola, et al.
Publicado: (2018)

Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder
por: Rashidian, Houman, et al.
Publicado: (2022)

Suicide reduction in Canada during the COVID-19 pandemic: lessons informing national prevention strategies for suicide reduction
por: McIntyre, Roger S, et al.
Publicado: (2021)

An App-Based Digit Symbol Substitution Test for Assessment of Cognitive Deficits in Adults With Major Depressive Disorder: Evaluation Study
por: McIntyre, Roger S, et al.
Publicado: (2022)

Comparing mortality from covid-19 to mortality due to overdose: A micromort analysis
por: Lee, Yena, et al.
Publicado: (2022)

Stability, reliability, and validity of the THINC‐it screening tool for cognitive impairment in depression: A psychometric exploration in healthy volunteers
por: Harrison, John E., et al.
Publicado: (2018)

Government response moderates the mental health impact of COVID-19: A systematic review and meta-analysis of depression outcomes across countries
por: Lee, Yena, et al.
Publicado: (2021)

Impact of SARS-CoV-2 Infection on Cognitive Function: A Systematic Review
por: Alnefeesi, Yazen, et al.
Publicado: (2021)

THINC-Integrated Tool (THINC-it): A Brief Measurement of Changes in Cognitive Functioning and Its Correlation with the Life Quality of Patients with Schizophrenia and Related Disorders—A Pilot Study
por: Szmyd, Joanna K., et al.
Publicado: (2023)

Changes in the gut microbiome associated with infliximab in patients with bipolar disorder
por: Bharwani, Aadil, et al.
Publicado: (2021)

Recognition and Treatment of Cognitive Dysfunction in Major Depressive Disorder
por: Zuckerman, Hannah, et al.
Publicado: (2018)

Onset and frequency of depression in post-COVID-19 syndrome: A systematic review
por: Renaud-Charest, Olivier, et al.
Publicado: (2021)

A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review
por: Pouyan, Niloufar, et al.
Publicado: (2022)

Physical activity preferences of individuals diagnosed with schizophrenia or bipolar disorder
por: Subramaniapillai, Mehala, et al.
Publicado: (2016)

Extracellular Vesicle Biomarkers Reveal Inhibition of Neuroinflammation by Infliximab in Association with Antidepressant Response in Adults with Bipolar Depression
por: Mansur, Rodrigo B., et al.
Publicado: (2020)

Real-world effectiveness of repeated ketamine infusions for treatment resistant depression during the COVID-19 pandemic
por: Rosenblat, Joshua D., et al.
Publicado: (2021)

Inflammation: opportunities for treatment stratification among individuals diagnosed with mood disorders
por: Subramaniapillai, Mehala, et al.
Publicado: (2017)

Screening Depressive Symptoms and Incident Major Depressive Disorder Among Chinese Community Residents Using a Mobile App–Based Integrated Mental Health Care Model: Cohort Study
por: Zhang, Huimin, et al.
Publicado: (2022)

Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis
por: Ceban, Felicia, et al.
Publicado: (2022)

COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis
por: Ceban, Felicia, et al.
Publicado: (2023)

Association between selective serotonin reuptake inhibitor and risk of peripheral artery disease in diabetes mellitus: Propensity score matching and landmark analysis
por: Chen, Kai-Hua, et al.
Publicado: (2022)

The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Rosenblat, Joshua D, et al.
Publicado: (2015)

The Association Between Concentrations of Arginine, Ornithine, Citrulline and Major Depressive Disorder: A Meta-Analysis
por: Fan, Mingyue, et al.
Publicado: (2021)

Reliability and Validity of THINC-it in Evaluating Cognitive Function of Patients with Bipolar Depression
por: Zhang, Weihua, et al.
Publicado: (2020)

Validation of the THINC-It Tool for Assessment of Cognitive Impairment in Patients with Bipolar Depression
por: Zhu, Na, et al.
Publicado: (2023)

Correction: Efficacy of omega-3 PUFAs in depression: A meta-analysis
por: Liao, Yuhua, et al.
Publicado: (2021)

Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications
por: Rosenblat, Joshua D., et al.
Publicado: (2017)

The Impact of Cognitive Behavioral Therapy on Peripheral Interleukin-6 Levels in Depression: A Systematic Review and Meta-Analysis
por: Ma, Haijing, et al.
Publicado: (2022)

Cognitive Deficits as a Mediator of Poor Occupational Function in Remitted Major Depressive Disorder Patients
por: Woo, Young Sup, et al.
Publicado: (2016)

Characterizing acyl-carnitine biosignatures for schizophrenia: a longitudinal pre- and post-treatment study
por: Cao, Bing, et al.
Publicado: (2019)

Predictive potential of somatic symptoms for the identification of subthreshold depression and major depressive disorder in primary care settings
por: Li, Xiuwen, et al.
Publicado: (2023)

Intravenous ketamine for depression: A clinical discussion reconsidering best practices in acute hypertension management
por: Yip, Ryan, et al.
Publicado: (2022)

Suicide prevention and ketamine: insights from computational modeling
por: Charlton, Colleen E., et al.
Publicado: (2023)

Preventing suicide in the context of the COVID‐19 pandemic
por: McIntyre, Roger S., et al.
Publicado: (2020)

Projected increases in suicide in Canada as a consequence of COVID-19
por: McIntyre, Roger S., et al.
Publicado: (2020)

Cognitive Function Mediates the Anti-suicide Effect of Repeated Intravenous Ketamine in Adult Patients With Suicidal Ideation
por: Zhou, Yanling, et al.
Publicado: (2022)

Further validation of the THINC‐it tool and extension of the normative data set in a study of n = 10.019 typical controls
por: Dalby, Maria, et al.
Publicado: (2022)

Coronary calcium score as an expression of multisystemic progression of bipolar disorder
por: Brietzke, Elisa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3drp567kkjcirmc4bjq2bgad6l